Novo Nordisk Heavily Undervalued, Market Outlook Upbeat

Novo Nordisk is seriously undervalued, with revenue and profit growth exceeding 20%, occupying a dominant position in the weight loss market, a 60% drop in stock price may be excessive, and the industry has huge growth potential

Latest News

08-25
期权女巫 | 减肥药巨头诺和诺德被严重低估,可以考虑Short Put了
期权女巫 | 减肥药巨头诺和诺德被严重低估,可以考虑Short Put了

User Discussion

avatarN30
08-26
$Novo-Nordisk A/S(NVO)$ Novo Nordisk dominates a booming industry. Even after the big run up, strong demand for its therapies could keep it a solid long-term play.